Elleste Solo 2 mg Tablets

Elleste Solo is a widely recognized Hormone Replacement Therapy (HRT) medication containing estradiol. The brand has a legacy involved with various pharmaceutical entities including GD Searle and Meda Pharmaceuticals. Currently, the brand is marketed under the Mylan brand identity, which is now part of Viatris Inc. following the 2020 merger between Mylan and Pfizer's Upjohn division.

Manufacturing of Elleste products occurs across a global network of pharmaceutical facilities, with significant production historically noted in Europe and North America to meet international quality standards. The ownership structure reflects the consolidation within the generic and specialty medicine industry, positioning the product within the extensive portfolio of Viatris, a global healthcare company headquartered in the United States.